Strategies for purging CD96(+) stem cells in vitro and in vivo: New avenues for autologous stem cell transplantation in acute myeloid leukemia

The persistence of leukemic stem cells (LSCs) in acute myeloid leukemia (AML) patients receiving chemotherapy may be responsible for the high frequency of relapse. The selective elimination of CD96(+) AML-LSCs by means of CD96-specific monoclonal antibodies may be a promising therapeutic approach an...

Descripción completa

Detalles Bibliográficos
Autores principales: Staudinger, Matthias, Humpe, Andreas, Gramatzki, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Author's View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716745/
https://www.ncbi.nlm.nih.gov/pubmed/23894710
http://dx.doi.org/10.4161/onci.24500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716745/
https://www.ncbi.nlm.nih.gov/pubmed/23894710
http://dx.doi.org/10.4161/onci.24500

Ejemplares similares